Stock RSLS RESHAPE LIFESCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News ReShape Lifesciences Inc. Other OTC

Equities

RSLS

US7611236032

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS
BU
RSLS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ReShape Lifesciences Inc. Is Fair to Shareholders
BU
ReShape Signs Merger Agreement With Vyome, Asset Sale Deal With Biorad; Shares Rise
MT
ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
AQ
Ninjour Health International Limited agreed to acquire Assets of ReShape Lifesciences Inc for $5.2 million.
CI
ReShape Lifesciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024
Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M
MT
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
AQ
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
AQ
North American Morning Briefing : Big Banks Kick -2-
DJ
Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
AQ
ReShape Lifesciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Certain Restricted Stock Units of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Warrants of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Options of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Common Stock of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
ReShape Lifesciences Gets US Patent for Intragastric Balloon Weight-Loss System
MT
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RSLS Stock
  4. RSLS Stock
  5. News ReShape Lifesciences Inc.